Document is current
Any future updates will be listed below
-
Authors
Paracha, Noman http://orcid.org/0000-0002-3438-4853
Reyes, Adriana
Diéras, Véronique
Krop, Ian
Pivot, Xavier
Urruticoechea, Ander
-
Funding
Funding for this research was provided by:
F. Hoffmann-La Roche
- License Information
-
More Information
Article History
Received: 29 August 2019
Accepted: 12 February 2020
First Online: 25 February 2020
Compliance with Ethical Standards
:
: NP is an employee of F. Hoffmann-La Roche AG and owns F. Hoffmann-La Roche AG stock. AR is an employee of F. Hoffmann-La Roche AG. VD Consultant/Advisory role: AbbVie, Astellas, AstraZeneca, Daiichi Sankyo, Eisai, Lilly, Merck Sharp & Dohme, Nektar, Novartis, Odonate, Pfizer, Roche/Genentech, Seattle Genetics, Tesaro. IK Consultant/Advisory role: Bristol-Myers Squibb, Context Therapeutics, Daiichi Sankyo, MacroGenics, Merck, Novartis, Roche/Genentech, Seattle Genetics, Taiho Oncology. XP has nothing to declare. AU has received travel support from Roche<b>.</b>
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Not applicable.
